DUOBRII
DUOBRII
Approved
DIN Number
02499967
Drug Class
Human
Market Date
Aug 4, 2020
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02499967
AIG Number0262297001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
D05AX05 TAZAROTENE
Product Specifications
Dosage FormLotion
Route of AdministrationTopical
AHFS Classification84:92.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
HALOBETASOL PROPIONATEActive
Strength: 0.01 % / W/W
Monograph: HALOBETASOL PROPIONATE
TAZAROTENEActive
Strength: 0.045 % / W/W
Monograph: TAZAROTENE